Biological correlation between HER-2/neu and proliferative activity in human breast cancer.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Anticancer Research

• Publication date

  1991-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1684096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• c-erbB2 expression in correlation to other biological parameters of breast cancer

  2005cited by this paper
• Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer.

  1991cited by this paper
• Follow-up study of HER-2/neu amplification in primary breast cancer.

  1991cited by this paper
• Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.

  1990cited by this paper
• Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells.

  1990cited by this paper
• HER-2/neu amplification predicts poor survival in node-positive breast cancer.

  1990cited by this paper
• correlation between histologic grade of malignancy and copy number of c‐erbb‐2 gene in breast carcinoma. A retrospective analysis of 176 cases

  1990cited by this paper
• Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.

  1990cited by this paper
• HER-2/neu oncogene expression and DNA ploidy analysis in breast cancer.

  1990cited by this paper
• Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.

  1990cited by this paper
• The neu‐oncogene protein as a predictive factor for haematogenous metastases in breast cancer patients

  1990cited by this paper
• Increased erbB-2 gene copies and expression in multiple stages of breast cancer.

  1990cited by this paper
• Amplification of the c-erb B-2 oncogene and prognosis of breast adenocarcinoma.

  1990cited by this paper
• HER2/neu amplification and comedo type breast carcinoma.

  1989cited by this paper
• A chimeric EGF‐R‐neu proto‐oncogene allows EGF to regulate neu tyrosine kinase and cell transformation.

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S‐phase fraction: A proposed classification of DNA histograms in breast cancer

  1988cited by this paper
• An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinoma.

  1988cited by this paper
• Amplification and over-expression of the neu oncogene in human breast carcinomas.

  1988cited by this paper
• Immunohistochemical distribution of c‐erbB‐2 in infiltrating and in situ breast cancer

  1988cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• Overexpression of the EGF receptor‐related proto‐oncogene erbB‐2 in human mammary tumor cell lines by different molecular mechanisms.

  1987cited by this paper
• Stage- and tissue-specific expression of the neu oncogene in rat development.

  1987cited by this paper
• erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.

  1987cited by this paper
• Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.

  1987cited by this paper
• Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies.

  1985cited by this paper
• Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.

  1983cited by this paper
• Neuroendocrine (Merkel cell) carcinomas of the skin: an ultrastructural study of nine cases.

  1981cited by this paper

• A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs

  2016cites this paper
• The role of systemic metabolism in breast cancer progression

  2015cites this paper
• Gene protein detection platform--a comparison of a new human epidermal growth factor receptor 2 assay with conventional immunohistochemistry and fluorescence in situ hybridization platforms.

  2015cites this paper
• Overview of resistance to systemic therapy in patients with breast cancer.

  2007cites this paper
• HER-2/neu evaluation in breast cancer are we there yet?

  2004cites this paper
• HER2/neu as a predictive factor in breast cancer.

  2001cites this paper
• Perceptions of Herceptin®: A Monoclonal Antibody for the Treatment of Breast Cancer

  1999cites this paper
• Poly(A)polymerase activity levels in breast tumour cytosols.

  1998cites this paper
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cites this paper
• ERBB2 oncogene in human breast cancer and its clinical significance.

  1998cites this paper
• p185 overexpression in 220 samples of breast cancer undergoing primary surgery: comparison with c-erbB-2 gene amplification.

  1998cites this paper
• Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer

  1997cites this paper
• Steroid hormones and cancer: (II) Lessons from experimental systems.

  1997cites this paper
• Steroid hormones and cancer: (II) lessons from experimental system

  1997cites this paper
• Cell kinetics in vivo of human breast cancer

  1996cites this paper
• HER-2/neu, c-Myc and cyclin-A in human breast cancer.

  1996cites this paper
• c‐erbB‐2/neu protein expression, DNA ploidy and S phase in breast cancer

  1996cites this paper
• ErbB-2 oncoprotein overexpression in breast carcinoma: Inverse correlation with biochemically- and immunohistochemically-determined hormone receptors

  1995cites this paper
• The Immunology of Breast Cancer

  1995cites this paper
• c‐erbB‐2 oncoprotein is not an independent prognostic parameter in primary breast carcinoma. An immunohistochemical study

  1994cites this paper
• Molecular mechanisms of chemical carcinogenesis in rodent models.

  1994cites this paper
• Recent developments in the molecular genetic understanding of breast cancer.

  1994cites this paper
• HER-2/neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma.

  1992cites this paper
• Expression of her-2/neu oncogene in breast-cancer - correlation of quantitative immunocytochemistry and prognostic factors.

  1992cites this paper
• HER-2/Neu Gene in Primary and Local Metastatic Axillary Lymph Nodes in Human Breast Tumors

  1992cites this paper
• HÓA MÔ MIỄN DỊCH TRONG UNG THƯ VÚ

  year unknowncites this paper